GlassScriptPhysician profile
Alice B Newell
NPI 1124181490
$1,263.78
in general payments reported to CMS, 2019-2025
16 companies · $298 in 2025
The $298 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $69.04 · 2021: $99.38 · 2022: $93.55 · 2023: $165 · 2024: $336 · 2025: $298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $799.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $799.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $237.36 | 2019-2025 | |
| Astellas Pharma US INC | $162.16 | 2020-2025 | Veozah |
| Pfizer INC. | $157.91 | 2022-2025 | |
| Amgen INC. | $142.89 | 2019-2025 | Evenity, Prolia |
| Organon LLC | $103.44 | 2022-2025 | Jada System, Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $101.10 | 2019-2025 | |
| Hologic Sales and Service, LLC | $80.40 | 2023-2025 | Aptima, Thinprep 2000 Processor |
| Avanos Medical | $62.96 | 2019 | |
| Lilly USA, LLC | $58.47 | 2024 | Zepbound |
| Biogen, INC. | $37.11 | 2025 | Zurzuvae |
| Minerva Surgical, INC | $30.16 | 2025 | |
| Amag Pharmaceuticals, INC. | $30.14 | 2019-2020 | |
| Exeltis, USA INC. | $17.36 | 2023 | Slynd |
| Merck Sharp & Dohme LLC | $16.12 | 2024 | Gardasil, Gardasil 9 |
| Medtronic, INC. | $13.71 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $12.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alice Newell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.